BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17825503)

  • 1. Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
    Yuasa K; Suzue K; Nagahama M; Matsuda Y; Tsuji A
    Gene; 2007 Nov; 402(1-2):103-10. PubMed ID: 17825503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors.
    Bakrania A; Aubé M; Desjardins R; Sabbagh R; Day R
    Can J Physiol Pharmacol; 2020 Jul; 98(7):477-481. PubMed ID: 32119574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of proprotein convertase PACE4 is highly regulated by Hash-2 in placenta: possible role of placenta-specific basic helix-loop-helix transcription factor, human achaete-scute homologue-2.
    Koide S; Yoshida I; Tsuji A; Matsuda Y
    J Biochem; 2003 Sep; 134(3):433-40. PubMed ID: 14561729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE; Mahloogi H; Klein-Szanto AJ
    Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4.
    Tsuji A; Kikuchi Y; Sato Y; Koide S; Yuasa K; Nagahama M; Matsuda Y
    Biochem J; 2006 May; 396(1):51-9. PubMed ID: 16433634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human subtilisin-like proprotein convertase, PACE4 (SPC4) gene expression is highly regulated through E-box elements in HepG2 and GH4C1 cells.
    Tsuji A; Yoshida S; Hasegawa S; Bando M; Yoshida I; Koide S; Mori K; Matsuda Y
    J Biochem; 1999 Sep; 126(3):494-502. PubMed ID: 10467164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation.
    Yuasa K; Masuda T; Yoshikawa C; Nagahama M; Matsuda Y; Tsuji A
    J Biochem; 2009 Sep; 146(3):407-15. PubMed ID: 19520771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proprotein convertase PACE4 is upregulated by PDGF-BB in megakaryocytes: gene expression of PACE4 and furin is regulated differently in Dami cells.
    Bando M; Matsuoka A; Tsuji A; Matsuda Y
    J Biochem; 2002 Jul; 132(1):127-34. PubMed ID: 12097169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1.
    Yoshida I; Koide S; Hasegawa SI; Nakagawara A; Tsuji A; Matsuda Y
    Biochem J; 2001 Dec; 360(Pt 3):683-9. PubMed ID: 11736660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve head.
    Fuller JA; Brun-Zinkernagel AM; Clark AF; Wordinger RJ
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5759-68. PubMed ID: 19339735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly regulated expression of subtilisin-like proprotein convertase PACE4 (SPC4) during dentinogenesis.
    Akamatsu T; Matsuda Y; Tsumura K; Tada J; Parvin MN; Wei W; Kanamori N; Hosoi K
    Biochem Biophys Res Commun; 2000 Jun; 272(2):410-5. PubMed ID: 10833428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway.
    Kang S; Zhao Y; Hu K; Xu C; Wang L; Liu J; Yao A; Zhang H; Cao F
    Prostate; 2014 Aug; 74(11):1095-106. PubMed ID: 24913567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium.
    Freyer C; Kilpatrick LM; Salamonsen LA; Nie G
    Reproduction; 2007 Jun; 133(6):1189-97. PubMed ID: 17636173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
    Fu Y; Campbell EJ; Shepherd TG; Nachtigal MW
    Mol Cancer Res; 2003 Jun; 1(8):569-76. PubMed ID: 12805404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
    Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
    Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of alpha1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2' residue in stable complex formation of the serpin with proprotein convertase.
    Tsuji A; Kanie H; Makise H; Yuasa K; Nagahama M; Matsuda Y
    Protein Eng Des Sel; 2007 Apr; 20(4):163-70. PubMed ID: 17351018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells.
    Mori K; Imamaki A; Nagata K; Yonetomi Y; Kiyokage-Yoshimoto R; Martin TJ; Gillespie MT; Nagahama M; Tsuji A; Matsuda Y
    J Biochem; 1999 Mar; 125(3):627-33. PubMed ID: 10050053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.